Vilex, Inc. – Trademark Portfolio

Entity Type: 03

Vilex, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include VILEX. The owner is based in Pittsburgh, PA.

345 Old Curry Hollow Road

Pittsburgh, PA 15236

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vilex, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Vilex, Inc. have?

Vilex, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned, 2 cancelled.

What trademark classes does Vilex, Inc. file in?

Vilex, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Vilex, Inc.'s most well-known trademarks?

Vilex, Inc.'s registered trademark portfolio includes well-known marks such as VILEX. These are among 1 currently registered trademark in the portfolio.

What is Vilex, Inc.'s trademark registration success rate?

Vilex, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.